1887
Preview this article:
Zoom in
Zoomout

No crucial amino acid changes in the predicted histo blood group antigen-binding sites of norovirus genotype GII.4 capsid between non-secretors and secretors origin might suggest an alternative route of infection or existence of coincidental molecules, Page 1 of 1

| /docserver/preview/fulltext/jmm/64/12/1544_jmm000178-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000178
2015-12-01
2020-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/12/1544.html?itemId=/content/journal/jmm/10.1099/jmm.0.000178&mimeType=html&fmt=ahah

References

  1. Allen D. J., Noad R., Samuel D., Gray J. J., Roy P., Iturriza-Gómara M.. ( 2009;). Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J 6: 150 [CrossRef] [PubMed].
    [Google Scholar]
  2. Bauer K.. ( 1997;). Foot-and-mouth disease as zoonosis. Arch Virol Suppl 13: (Suppl.), 95–97 [PubMed].
    [Google Scholar]
  3. Carlsson B., Kindberg E., Buesa J., Rydell G. E., Lidón M. F., Montava R., Abu Mallouh R., Grahn A., Rodríguez-Díaz J., other authors. ( 2009;). The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 norovirus infection. PLoS One 4: e5593 [CrossRef] [PubMed].
    [Google Scholar]
  4. Debbink K., Lindesmith L. C., Donaldson E. F., Costantini V., Beltramello M., Corti D., Swanstrom J., Lanzavecchia A., Vinjé J., Baric R. S.. ( 2013;). Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis 208: 1877–1887 [CrossRef] [PubMed].
    [Google Scholar]
  5. Henry S., Mollicone R., Fernandez P., Samuelsson B., Oriol R., Larson G.. ( 1996;). Molecular basis for erythrocyte Le(a+b+) and salivary ABH partial-secretor phenotypes: expression of a FUT2 secretor allele with an A → T mutation at nucleotide 385 correlates with reduced α(1,2) fucosyltransferase activity. Glycoconj J 13: 985–993 [CrossRef] [PubMed].
    [Google Scholar]
  6. Hutson A. M., Atmar R. L., Graham D. Y., Estes M. K.. ( 2002;). Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185: 1335–1337 [CrossRef] [PubMed].
    [Google Scholar]
  7. Jin M., He Y., Li H., Huang P., Zhong W., Yang H., Zhang H., Tan M., Duan Z. J.. ( 2013;). Two gastroenteritis outbreaks caused by GII noroviruses: host susceptibility and HBGA phenotypes. PLoS One 8: e58605 [CrossRef] [PubMed].
    [Google Scholar]
  8. Jones M. K., Watanabe M., Zhu S., Graves C. L., Keyes L. R., Grau K. R., Gonzalez-Hernandez M. B., Iovine N. M., Wobus C. E., other authors. ( 2014;). Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346: 755–759 [CrossRef] [PubMed].
    [Google Scholar]
  9. Kelly R. J., Rouquier S., Giorgi D., Lennon G. G., Lowe J. B.. ( 1995;). Sequence and expression of a candidate for the human Secretor blood group α(1,2)fucosyltransferase gene (FUT2): homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270: 4640–4649 [CrossRef] [PubMed].
    [Google Scholar]
  10. Kindberg E., Akerlind B., Johnsen C., Knudsen J. D., Heltberg O., Larson G., Böttiger B., Svensson L.. ( 2007;). Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol 45: 2720–2722 [CrossRef] [PubMed].
    [Google Scholar]
  11. Koda Y., Soejima M., Kimura H.. ( 2001;). The polymorphisms of fucosyltransferases. Leg Med (Tokyo) 3: 2–14 [CrossRef] [PubMed].
    [Google Scholar]
  12. Kojima S., Kageyama T., Fukushi S., Hoshino F. B., Shinohara M., Uchida K., Natori K., Takeda N., Katayama K.. ( 2002;). Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods 100: 107–114 [CrossRef] [PubMed].
    [Google Scholar]
  13. Kudo T., Iwasaki H., Nishihara S., Shinya N., Ando T., Narimatsu I., Narimatsu H.. ( 1996;). Molecular genetic analysis of the human Lewis histo-blood group system. II. Secretor gene inactivation by a novel single missense mutation A385T in Japanese nonsecretor individuals. J Biol Chem 271: 9830–9837 [CrossRef] [PubMed].
    [Google Scholar]
  14. Larsson M. M., Rydell G. E. P., Grahn A., Rodriguez-Diaz J., Akerlind B., Hutson A. M., Estes M. K., Larson G., Svensson L.. ( 2006;). Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis 194: 1422–1427 [CrossRef] [PubMed].
    [Google Scholar]
  15. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., Stewart P., LePendu J., Baric R.. ( 2003;). Human susceptibility and resistance to Norwalk virus infection. Nat Med 9: 548–553 [CrossRef] [PubMed].
    [Google Scholar]
  16. Lindesmith L. C., Donaldson E. F., Lobue A. D., Cannon J. L., Zheng D. P., Vinje J., Baric R. S.. ( 2008;). Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 5:,0 e31 [CrossRef] [PubMed].
    [Google Scholar]
  17. Lindesmith L. C., Beltramello M., Donaldson E. F., Corti D., Swanstrom J., Debbink K., Lanzavecchia A., Baric R. S.. ( 2012;). Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 8: e1002705 [CrossRef] [PubMed].
    [Google Scholar]
  18. Lindesmith L. C., Costantini V., Swanstrom J., Debbink K., Donaldson E. F., Vinjé J., Baric R. S.. ( 2013;). Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol 87: 2803–2813 [CrossRef] [PubMed].
    [Google Scholar]
  19. Liu P., Wang X., Lee J. C., Teunis P., Hu S., Paradise H. T., Moe C.. ( 2014;). Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease. Pediatr Infect Dis J 33: e305–e309 [CrossRef] [PubMed].
    [Google Scholar]
  20. Marionneau S., Ruvoën N., Le Moullac-Vaidye B., Clement M., Cailleau-Thomas A., Ruiz-Palacois G., Huang P., Jiang X., Le Pendu J.. ( 2002;). Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122: 1967–1977 [CrossRef] [PubMed].
    [Google Scholar]
  21. Rouquier S., Lowe J. B., Kelly R. J., Fertitta A. L., Lennon G. G., Giorgi D.. ( 1995;). Molecular cloning of a human genomic region containing the H blood group α(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270: 4632–4639 [CrossRef] [PubMed].
    [Google Scholar]
  22. Shanker S., Choi J. M., Sankaran B., Atmar R. L., Estes M. K., Prasad B. V. V.. ( 2011;). Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol 85: 8635–8645 [CrossRef] [PubMed].
    [Google Scholar]
  23. Tan M., Jin M., Xie H., Duan Z., Jiang X., Fang Z.. ( 2008;). Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 80: 1296–1301 [CrossRef] [PubMed].
    [Google Scholar]
  24. Tan M., Xia M., Chen Y., Bu W., Hegde R. S., Meller J., Li X., Jiang X.. ( 2009;). Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One 4: e5058 [CrossRef] [PubMed].
    [Google Scholar]
  25. Thorven M., Grahn A., Hedlund K.-O., Johansson H., Wahlfrid C., Larson G., Svensson L.. ( 2005;). A homozygous nonsense mutation (428G → A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 79: 15351–15355 [CrossRef] [PubMed].
    [Google Scholar]
  26. Yoda T., Suzuki Y., Yamazaki K., Sakon N., Kanki M., Kase T., Takahashi K., Inoue K.. ( 2009;). Application of a modified loop-mediated isothermal amplification kit for detecting norovirus genogroups I and II. J Med Virol 81: 2072–2078 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000178
Loading
/content/journal/jmm/10.1099/jmm.0.000178
Loading

Data & Media loading...

Supplements

Supplementary Data



PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error